Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Van Hemelrijck, Mieke"'
Autor:
Nakamura, Mano, Bax, Heather J., Scotto, Daniele, Souri, Elmira Amiri, Sollie, Sam, Harris, Robert J., Hammar, Niklas, Walldius, Goran, Winship, Anna, Ghosh, Sharmistha, Montes, Ana, Spicer, James F., Van Hemelrijck, Mieke, Josephs, Debra H., Lacy, Katie E., Tsoka, Sophia, Karagiannis, Sophia N.
Publikováno v:
Oncoimmunology
Nakamura, M, Bax, H J, Scotto, D, Amiri Souri, E, Sollie, S, Harris, R J, Hammar, N, Walldius, G, Winship, A, Ghosh, S, Montes, A, Spicer, J F, Van Hemelrijck, M, Josephs, D H, Lacy, K E, Tsoka, S & Karagiannis, S N 2019, ' Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma ', OncoImmunology, vol. 8, no. 6, e1593811 . https://doi.org/10.1080/2162402X.2019.1593811
OncoImmunology, Vol 8, Iss 6 (2019)
Nakamura, M, Bax, H J, Scotto, D, Amiri Souri, E, Sollie, S, Harris, R J, Hammar, N, Walldius, G, Winship, A, Ghosh, S, Montes, A, Spicer, J F, Van Hemelrijck, M, Josephs, D H, Lacy, K E, Tsoka, S & Karagiannis, S N 2019, ' Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma ', OncoImmunology, vol. 8, no. 6, e1593811 . https://doi.org/10.1080/2162402X.2019.1593811
OncoImmunology, Vol 8, Iss 6 (2019)
Immune and inflammatory cascades may play multiple roles in ovarian cancer. We aimed to identify relationships between expression of immune and inflammatory mediators and patient outcomes. We interrogated differential gene expression of 44 markers an
Autor:
De Piano M; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK., Manuelli V; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK., Zadra G; Departments of Oncologic Pathology and Pathology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Loda M; Departments of Oncologic Pathology and Pathology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Muir G; Urology, King's College Hospital, London, UK., Chandra A; Cellular Pathology, St. Thomas' Hospital, London, UK., Morris J; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK., Wells CM; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK.
Publikováno v:
Small GTPases [Small GTPases] 2021 Jul; Vol. 12 (4), pp. 265-272. Date of Electronic Publication: 2020 Oct 12.
Autor:
Wulaningsih W; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK; Division of Hematology/Oncology, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia., Holmberg L; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Regional Cancer Centre, Uppsala, Sweden., Garmo H; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London, NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, London, UK., Karagiannis SN; St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London, NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London , London, UK., Ahlstedt S; Center of Allergy Research, Institute of Environmental Medicine, Karolinska Insitutet , Stockholm, Sweden., Malmstrom H; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet , Stockholm, Sweden., Lambe M; Regional Cancer Centre, Uppsala, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; AstraZeneca R&D, Mölndal, Sweden., Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet , Stockholm, Sweden., Jungner I; Department of Medicine, Clinical Epidemiological Unit, Karolinska Institutet and CALAB Research , Stockholm, Sweden., Ng T; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer Studies, King's College London , London, UK., Van Hemelrijck M; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Mar 28; Vol. 5 (6), pp. e1154250. Date of Electronic Publication: 2016 Mar 28 (Print Publication: 2016).
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.
Autor:
Karagiannis P; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK ; University Hospital of Hamburg Eppendorf; Department of Oncology; Hematology and Stem Cell Transplantation ; Hamburg, Germany., Villanova F; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Josephs DH; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK ; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Correa I; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Van Hemelrijck M; King's College London; Faculty of Life Sciences and Medicine; Division of Cancer Studies; Cancer Epidemiology Group; Guy's Hospital; London, UK., Hobbs C; Wolfson Center for Age-Related Diseases; King's College London ; London, UK., Saul L; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK ; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Egbuniwe IU; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Tosi I; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Ilieva KM; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK ; Breakthrough Breast Cancer Research Unit; Department of Research Oncology; Guy's Hospital; King's College London School of Medicine ; London, United Kingdom., Kent E; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Calonje E; Skin Tumor Unit; St. John's Institute of Dermatology; Guy's Hospital, King's College London and Guy's and St Thomas' NHS Trust ; London, UK., Harries M; Clinical Oncology; Guy's and St. Thomas's NHS Foundation Trust , London, UK., Fentiman I; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Taylor-Papadimitriou J; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Burchell J; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Spicer JF; Department of Research Oncology; Division of Cancer Studies; Faculty of Life Sciences and Medicine; King's College London; Guy's Hospital ; London, UK., Lacy KE; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK ; Skin Tumor Unit; St. John's Institute of Dermatology; Guy's Hospital, King's College London and Guy's and St Thomas' NHS Trust ; London, UK., Nestle FO; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK., Karagiannis SN; St. John's Institute of Dermatology; Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London ; London, UK.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2015 Jun 03; Vol. 4 (11), pp. e1032492. Date of Electronic Publication: 2015 Jun 03 (Print Publication: 2015).
Autor:
Van Hemelrijck M; Division of Cancer Studies, Cancer Epidemiology Group, School of Medicine, King's College London , London , UK ., Michaelsson K, Nelson WG, Kanarek N, Dobs A, Platz EA, Rohrmann S
Publikováno v:
The aging male : the official journal of the International Society for the Study of the Aging Male [Aging Male] 2013 Dec; Vol. 16 (4), pp. 151-8. Date of Electronic Publication: 2013 May 14.